Hyun Jung Sohn

Title: Hyun Jung Sohn: Innovator in Immunology

Introduction

Hyun Jung Sohn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in the development of innovative therapies for cancer and autoimmune diseases. With a total of 4 patents, his work is paving the way for new treatment options.

Latest Patents

One of his latest patents is titled "Exosome for stimulating T cell and pharmaceutical use thereof." This invention focuses on immune exosomes secreted from artificial antigen-presenting cells that express various co-stimulatory molecules. These exosomes are designed to stimulate naive CD8+ T cells, providing preventive and therapeutic effects against tumors, pathogen infections, and autoimmune diseases. Another notable patent is "Feeder cell and method for growing gamma delta T cells by using same." This invention describes a novel feeder cell and method for growing gamma delta T cells in vitro with high purity. The method allows for the differentiation into central memory cells and enhances the cytolytic activity against tumor cells.

Career Highlights

Hyun Jung Sohn has worked with the Catholic University of Korea Industry-Academic Cooperation Foundation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of T cell stimulation and growth.

Collaborations

He has collaborated with notable colleagues, including Tai Gyu Kim and Su Eon Kim, who have supported his research endeavors.

Conclusion

Hyun Jung Sohn's innovative work in immunology is making a significant impact on the development of new therapies for critical health issues. His patents reflect a commitment to advancing medical science and improving patient outcomes.